Tenet Healthcare Corporation (THC) Stock Price Today
Aura AI Summary
Key Stats
- $20.96BMarket Cap
- -Volume
- HealthSector
- $244.8052W High
- $156.0652W Low
- -Typical Hold Time
- $32.04BEnterprise Value
- -Div Yield
- -Trading Activity
Track Tenet Healthcare Corporation (THC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Tenet Healthcare Corporation has traded between a low of $156.06 and a high of $248.21, highlighting its annual price range. Buy and sell Tenet Healthcare Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Most Recent News
Roblox sees rising engagement among 17-25 year-olds in Q2 2026, with growing weekly users and playtime.
Apptopia's report reveals that Roblox Corporation experienced growth in Weekly Active Users and average time spent per daily active user among the 17-25 age group during Q2 2026, continuing into July. This trend highlights increasing engagement from ...

LEPAS launches global lineup of elegant NEVs including L4 EV, L6 EV, and L8 PHEV models
LEPAS, Chery Auto's mid-to-premium new energy vehicle (NEV) brand, has introduced a global lineup featuring the LEPAS L4 EV, L6 EV, and L8 PHEV. These models emphasize elegant design, intelligent technology, and versatile space to meet diverse global...

Implicity's AI ECG Analyzer gets FDA clearance, cutting false alerts from cardiac monitors by 76%.
Implicity received FDA clearance for its next-generation ILR ECG Analyzer, an AI-powered cloud software that reduces false-positive alerts from implantable cardiac monitors by up to 76% while maintaining high sensitivity for true cardiac events. The ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.